학술논문
Radiotherapy with cetuximab or durvalumab for locoregionally advanced head and neck cancer in patients with a contraindication to cisplatin (NRG-HN004): an open-label, multicentre, parallel-group, randomised, phase 2/3 trial
Document Type
Article
Author
Mell, Loren K ; Torres-Saavedra, Pedro A ; Wong, Stuart J ; Kish, Julie A ; Chang, Steven S ; Jordan, Richard C ; Liu, Tian ; Truong, Minh Tam ; Winquist, Eric W ; Takiar, Vinita ; Wise-Draper, Trisha ; Robbins, Jared R ; Rodriguez, Cristina P ; Awan, Musaddiq J ; Beadle, Beth M ; Henson, Christina ; Narayan, Samir ; Spencer, Sharon A ; Powell, Steven ; Dunlap, Neal ; Sacco, Assuntina G ; Hu, Kenneth Shung ; Park, Henry S ; Bauman, Julie E ; Harris, Jonathan ; Yom, Sue S ; Le, Quynh-Thu
Source
In The Lancet Oncology December 2024 25(12):1576-1588
Subject
Language
ISSN
1470-2045
Abstract
Funding US National Cancer Institute and AstraZeneca.